Skip to main content
Jason Mendler, MD, Oncology, Rochester, NY

Jason Harold Mendler MD

Hematologic Oncology


Assistant Professor, Medicine, University of Rochester School of Medicine & Dentistry

Join to View Full Profile
  • 601 Elmwood AveBox MedRochester, NY 14642

  • Phone+1 585-275-5823

  • Fax+1 585-273-1051

Dr. Mendler is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Ohio State University Hospital
    Ohio State University HospitalFellowship, Hematology and Medical Oncology, 2009 - 2011
  • University of Rochester Medical Center
    University of Rochester Medical CenterResidency, Internal Medicine, 2005 - 2008
  • University of Rochester School of Medicine and Dentistry
    University of Rochester School of Medicine and DentistryClass of 2005

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2007 - 2027
  • OH State Medical License
    OH State Medical License 2009 - 2012
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Preliminary Results from a Phase II Study of the Combination of Pevonedistat and Azacitidine in the Treatment of MDS and MDS/MPN after Failure of DNA Methyltransferase...
    Jason H. Mendler, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

  • Qualitative Study of Factors That Influence Treatment Decision-Making Among Community Oncologists and Older Patients with Acute Myeloid Leukemia 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Access and Referral Barriers to Autologous and Allogeneic Hematopoietic Cell Transplantation in Adult Patients with Cancer: A Systematic Review with a Specific Focus o... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • S1712 Supports Adding Ruxolitinib to TKIs for CML
    S1712 Supports Adding Ruxolitinib to TKIs for CMLSeptember 20th, 2024
  • As Leukemia Evolves, Stem Cells Hold Keys to Newer Therapies
    As Leukemia Evolves, Stem Cells Hold Keys to Newer TherapiesAugust 29th, 2016

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: